In contrast, genetic ablation of CtsB in AD mice resulted in increased amounts of Aβ1–42 and a more abundant plaque deposition pattern, suggesting an antiamyloidogenic role of CtsB [13]. The gene discussed is CTSB; the disease is Alzheimer disease.